Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MM-Predict: MMP2 and MMP9 Expression in Newly Diagnosed Glioblastoma
NCT03526822Recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jul 2018
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Correlation of plasma levels of MMP2 and MMP9 to their RNA and protein tissue expression at 18 months. Started Jul 2018; status: recruiting.
Beyond the preview
Go deeper on NCT03526822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03526822.